BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 29326099)

  • 1. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.
    Weiss ES; Girard-Guyonvarc'h C; Holzinger D; de Jesus AA; Tariq Z; Picarsic J; Schiffrin EJ; Foell D; Grom AA; Ammann S; Ehl S; Hoshino T; Goldbach-Mansky R; Gabay C; Canna SW
    Blood; 2018 Mar; 131(13):1442-1455. PubMed ID: 29326099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
    Jamilloux Y; Lefeuvre L; Magnotti F; Martin A; Benezech S; Allatif O; Penel-Page M; Hentgen V; Sève P; Gerfaud-Valentin M; Duquesne A; Desjonquères M; Laurent A; Rémy-Piccolo V; Cimaz R; Cantarini L; Bourdonnay E; Walzer T; Py BF; Belot A; Henry T
    Rheumatology (Oxford); 2018 Jan; 57(1):100-111. PubMed ID: 29040788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18.
    Alehashemi S; Goldbach-Mansky R
    Front Immunol; 2020; 11():1840. PubMed ID: 32983099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome.
    Barsalou J; Blincoe A; Fernandez I; Dal-Soglio D; Marchitto L; Selleri S; Haddad E; Benyoucef A; Touzot F
    Front Immunol; 2018; 9():2162. PubMed ID: 30319625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection.
    Guo Y; Li L; Xu T; Guo X; Wang C; Li Y; Yang Y; Yang D; Sun B; Zhao X; Shao G; Qi X
    J Clin Invest; 2020 Dec; 130(12):6301-6316. PubMed ID: 33104527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.
    Canna SW; de Jesus AA; Gouni S; Brooks SR; Marrero B; Liu Y; DiMattia MA; Zaal KJ; Sanchez GA; Kim H; Chapelle D; Plass N; Huang Y; Villarino AV; Biancotto A; Fleisher TA; Duncan JA; O'Shea JJ; Benseler S; Grom A; Deng Z; Laxer RM; Goldbach-Mansky R
    Nat Genet; 2014 Oct; 46(10):1140-6. PubMed ID: 25217959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammasome-dependent Mechanisms Involved in Sensing and Restriction of Bacterial Replication.
    Andrade WA; Zamboni DS
    Curr Issues Mol Biol; 2018; 25():99-132. PubMed ID: 28875942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation.
    Qiu Q; Yang Z; Cao F; Yang C; Hardy P; Yan X; Yang S; Xiong W
    Exp Cell Res; 2020 Jan; 386(2):111737. PubMed ID: 31759058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial Outer Membrane Vesicle-Mediated Cytosolic Delivery of Flagellin Triggers Host NLRC4 Canonical Inflammasome Signaling.
    Yang J; Hwang I; Lee E; Shin SJ; Lee EJ; Rhee JH; Yu JW
    Front Immunol; 2020; 11():581165. PubMed ID: 33312172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis.
    Soares JL; Oliveira EM; Pontillo A
    Mult Scler Relat Disord; 2019 Apr; 29():26-34. PubMed ID: 30658261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammasome Activation in Ankylosing Spondylitis Is Associated With Gut Dysbiosis.
    Guggino G; Mauro D; Rizzo A; Alessandro R; Raimondo S; Bergot AS; Rahman MA; Ellis JJ; Milling S; Lories R; Elewaut D; Brown MA; Thomas R; Ciccia F
    Arthritis Rheumatol; 2021 Jul; 73(7):1189-1199. PubMed ID: 33452867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of macrophage activation syndrome.
    Schulert GS; Cron RQ
    Genes Immun; 2020 May; 21(3):169-181. PubMed ID: 32291394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious.
    Ceballos-Olvera I; Sahoo M; Miller MA; Del Barrio L; Re F
    PLoS Pathog; 2011 Dec; 7(12):e1002452. PubMed ID: 22241982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NLRP3 inflammasome activation by cell-permeable stapled peptides.
    Pal A; Neo K; Rajamani L; Ferrer FJ; Lane DP; Verma CS; Mortellaro A
    Sci Rep; 2019 Mar; 9(1):4913. PubMed ID: 30894604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice.
    Girard-Guyonvarc'h C; Palomo J; Martin P; Rodriguez E; Troccaz S; Palmer G; Gabay C
    Blood; 2018 Mar; 131(13):1430-1441. PubMed ID: 29295842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interface.
    Moghaddas F; Zeng P; Zhang Y; Schützle H; Brenner S; Hofmann SR; Berner R; Zhao Y; Lu B; Chen X; Zhang L; Cheng S; Winkler S; Lehmberg K; Canna SW; Czabotar PE; Wicks IP; De Nardo D; Hedrich CM; Zeng H; Masters SL
    J Allergy Clin Immunol; 2018 Dec; 142(6):1956-1967.e6. PubMed ID: 29778503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of inflammasomes in host defense against Citrobacter rodentium infection.
    Liu Z; Zaki MH; Vogel P; Gurung P; Finlay BB; Deng W; Lamkanfi M; Kanneganti TD
    J Biol Chem; 2012 May; 287(20):16955-64. PubMed ID: 22461621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis.
    Paramel Varghese G; Folkersen L; Strawbridge RJ; Halvorsen B; Yndestad A; Ranheim T; Krohg-Sørensen K; Skjelland M; Espevik T; Aukrust P; Lengquist M; Hedin U; Jansson JH; Fransén K; Hansson GK; Eriksson P; Sirsjö A
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.
    Iannitti RG; Napolioni V; Oikonomou V; De Luca A; Galosi C; Pariano M; Massi-Benedetti C; Borghi M; Puccetti M; Lucidi V; Colombo C; Fiscarelli E; Lass-Flörl C; Majo F; Cariani L; Russo M; Porcaro L; Ricciotti G; Ellemunter H; Ratclif L; De Benedictis FM; Talesa VN; Dinarello CA; van de Veerdonk FL; Romani L
    Nat Commun; 2016 Mar; 7():10791. PubMed ID: 26972847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The autoinflammation-associated NLRC4
    Eeckhout E; Asaoka T; Van Gorp H; Demon D; Girard-Guyonvarc'h C; Andries V; Vereecke L; Gabay C; Lamkanfi M; van Loo G; Wullaert A
    Front Immunol; 2023; 14():1272639. PubMed ID: 38090573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.